Answers are grounded in this paper and cite their sources.
Traditional herbal medicines are practiced worldwide for treatment of type II diabetes mellitus since ancient times. Gymnema sylvestre R. Br. has been used in ayurvedic medicine for the treatment of diabetes. Our target was to investigate the -amylase, -glucosidase and aldose reductase inhibitory along with antiglycation potential of methanolic extract of G. sylvestre and molecular docking of dihydroxy gimnemic triacetate. The enzyme inhibitory study revealed that G. sylvestre showed prominent -amylase, -glucosidase and aldose reductase inhibitory potential (42.49%, 47.21% and 38.93%) at concentration 200 g/ml, respectively. In glycation inhibitory activity, fructosamine inhibitory potential was found to be 36.22%, protein carbonyls were inhibited up to 15.56% whereas protein thiols were inhibited up to 67.84%. It shows, G. sylvestre significantly inhibited (p<0.001) activity of -amylase, -glucosidase and aldose reductase. The interaction of dihydroxy G. triacetate with these enzymes were validated by docking studies. The docking study showed the remarkable binding of -amylase, -glucosidase and aldose reductase with Dihydroxy G. Triacetate. Molecular docking study, which can be concluded that the phytochemicals have enhanced binding sites, interactions and potent inhibitory effect on enzyme activity. The results indicate that the significant antidiabetic properties of these G. sylvestre and its phytochemicals may attribute to its -amylase, -glucosidase and aldose reductase.
No takes yet. Share an insight, caveat, or question.
Kamalakkannan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: